MedPath

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Phase 3
Conditions
HIV Infections
Registration Number
NCT00009061
Lead Sponsor
Glaxo Wellcome
Brief Summary

The purpose of this study is to compare virus response to GW433908/ritonavir (RTV) to viral response to nelfinavir (NFV) when used with abacavir (ABC)/lamivudine (3TC) in patients that have not taken antiretroviral (ART) drugs.

Detailed Description

Patients are randomized to 1 of 2 treatment arms. One arm is treated with GW433908/RTV plus ABC and 3TC. The other is treated with NFV plus ABC and 3TC. Each group is treated for 48 weeks. The following are compared in the 2 arms: 1) magnitude and durability of antiviral response; 2) safety, tolerance, and antiviral response after 24 and 48 weeks of therapy; 3) time to treatment failure; 4) immunologic response; 5) occurrence of events related to metabolic abnormalities; and 6) development of viral resistance in a subset of patients following treatment. Also studied are: 1) steady-state plasma drug trough concentrations; 2) demographic, virologic, immunologic, pharmacologic, and adherence factors that may be associated with treatment outcome; 3) patient adherence to the drug regimens; 4) study medication utilization; and 5) resource utilization.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
624
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (37)

Orange County Ctr for Special Immunology

🇺🇸

Fountain Valley, California, United States

AIDS Healthcare Foundation

🇺🇸

Los Angeles, California, United States

LAGLC

🇺🇸

Los Angeles, California, United States

Kaiser Hospital

🇺🇸

Sacramento, California, United States

Park Ctr for Health / Keith Vrhel

🇺🇸

San Diego, California, United States

AIDS Research Alliance

🇺🇸

West Hollywood, California, United States

Dupont Circle Physicians Group

🇺🇸

Washington, District of Columbia, United States

Infectious Disease Consultants

🇺🇸

Altamonte Springs, Florida, United States

CRI of South Florida

🇺🇸

Coral Gables, Florida, United States

Therafirst Med Ctr

🇺🇸

Fort Lauderdale, Florida, United States

Scroll for more (27 remaining)
Orange County Ctr for Special Immunology
🇺🇸Fountain Valley, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.